The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Rodriguez
W J
WJ
Department of Infectious Diseases, Children's National Medical Center, Washington, D.C.
Wiedermann
B L
BL
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077722:Ceftibuten; D015296:Ceftizoxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002444:Cefuroxime / Q000031:analogs & derivatives / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002648:Child; D017291:Clarithromycin / Q000627:therapeutic use; D024841:Fluoroquinolones; D006801:Humans; D000097627:Cefpodoxime Proxetil; D000097670:Cefprozil
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D017963:Azithromycin; D020682:Cefixime; D002439:Cefotaxime; D000077722:Ceftibuten; D015296:Ceftizoxime; D002444:Cefuroxime; D002511:Cephalosporins; D017291:Clarithromycin; D024841:Fluoroquinolones; D000097627:Cefpodoxime Proxetil; D000097670:Cefprozil; C054920:loracarbef; C040738:cefuroxime axetil